Ibuprofen: A journey from prescription to over-the-counter use

Journal of the Royal Society of Medicine, Supplement

Volumn 100, Issue 48, 2007, Pages 2-6

  Moore, Nicholas ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CELECOXIB; DICLOFENAC; DIURETIC AGENT; IBUPROFEN; KETOPROFEN; NAPROXEN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ABDOMINAL PAIN; ANALGESIA; ARTHRITIS; BACKACHE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG BINDING; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; KIDNEY FAILURE; MUSCULOSKELETAL DISEASE; NEPHROTOXICITY; OSTEOARTHRITIS; PAIN; PEPTIC ULCER; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SORE THROAT; TOOTH PAIN; TREATMENT DURATION; ULCER; UNSPECIFIED SIDE EFFECT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUGS, NON-PRESCRIPTION; HUMANS; IBUPROFEN; PRESCRIPTIONS, DRUG;

EID: 38849123742     PISSN: 02675331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Doyle G, Furey S, Berlin R, et al. GI safety and tolerance of ibuprofen at maximum over-the-counter dose. Aliment Pharmacol Ther 1999;13:897-906
2. Mehlisch D. The efficacy of combination analgesic therapy in relieving dental pain. JADA 2002;133:861-71
3. Ganzberg S. Analgesics: opioids and nonopioids. In: Ciancio SC (ed). ADA Guide to Dental Therapeutics. Chicago: ADA Publishing, 1998:80-107
4. Eisenberg E, Berkey CS, Carr DB, et al. Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol 1994;12:2756-65
5. Black P, Mitchell MD, Desjardins P, et al. A randomized, double-blind, placebo-controlled comparison of the analgesic efficacy, onset of action, and tolerability of ibuprofen arginate and ibuprofen in postoperative dental pain. Clin Ther 2002;24:1072-89
6. Sachs C. Oral analgesics for acute nonspecific pain. Am Fam Physician 2005;71:913-8
7. Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in risk of GI complications with individual non-steroidal anti-inflammatory drugs: results of collaborative met-analysis. BMJ 1996;312:1563-6
8. Henry D, McGettigan P. Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs. IJCP 2003;135(suppl):43-9
9. Hawkey CJ, Cullen DJ, Pearson G, et al. Ibuprofen versus other non-steroidal anti-inflammatory drugs: use in general practice and patient perception. Aliment Pharmacol Ther 2000;14:187-91
10. Beaver WT. Review of the analgesic efficacy of ibuprofen. IJCP 2003;135(suppl):13-7
11. Ecker-Schlipf B. Ibuprofen is more effective and safer than paracetamol. Med Monatsschr Pharm 2006;29:43
12. Rainsford KD, Roberts SC, Brown S. Ibuprofen and paracetamol: relative safety in non-prescription dosages. J Pharm Pharmacol 1997;49:345-76
13. Fries J, Bruce B. Rates of serious GI events from low dose use of acetylsalicylic acid, acetaminophen and ibuprofen in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 2003;30:2226- 33
14. Moore N, van Ganse E, Le Parc JM, et al. The PAIN study: paracetamol, aspirin and ibuprofen new tolerability study. A large-scale, randomized clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesia. Clin Drug Invest 1999;18:89-98
15. Peterson GM. Risk factors... but only after excluding high-risk subjects. Pharmacoepidemiol Drug Saf 2004;13:253; author reply 255-6
16. Peterson GM. Selecting nonprescription analgesics. Am J Ther 2005;12:67-79
17. Depont F, Fourrier A, Merliere Y, et al. Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study. Pharmacoepidemiol Drug Saf 2007;16:891-900
18. Hasford J, Moore N, Hoye K. Safety and usage pattern of low-dose diclofenac when used as an over-the-counter medication: results of an observational cohort study in a community-based pharmacy setting. Int J Clin Pharmacol Ther 2004;42:415-22
19. Layton D, Sinclair H, Bond C, Hannaford P, Shakir S. Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK. Pharmacoepidemiol Drug Saf 2002;11:503-13
20. Moore N, Verschuren X, Montout C, Callens J, Kong SX, Begaud B. Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice. Therapie 2000;55:133-6
21. Moore N. Place of OTC analgesics and NSAIDs in osteoarthritis. Inflammopharmacology 2003;11:355-62
22. Moore N, Charlesworth A, VanGanse E, Jones JK. Solving Mr Peterson's doubts. Pharmacoepidemiol Drug Saf 2004;13:255-6
23. Paulose-Ram R, Hirsch R, Dillon C, Losonczy K, Cooper M, Ostchega Y. Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Saf 2003;12:315-26
24. Porteous T, Bond C, Hannaford P, Sinclair H. How and why are non-prescription analgesics used in Scotland? Fam Pract 2005;22:78-85
25. Sinclair H, Bond C, Hannaford P. Over-the-counter Ibuprofen: how and why is it used? Int J Pharm Practice 2000;8:121-7
26. Turunen JH, Mantyselka PT, Kumpusalo EA, Ahonen RS. Frequent analgesic use at population level: prevalence and patterns of use. Pain 2005;115:374-81
27. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. JAMA 1995;273:929-33
28. Rampal P, Moore N, van Ganse E, et al. Gastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at over-the-counter doses. J Int Med Res 2002;30:301-8
29. Murray MD, Brater DC. Renal effects of ibuprofen. Rainsford KD (ed). Ibuprofen. A Critical Bibliographic Review. London: Taylor and Francis, Inc, 1999:459-95
30. Furey SA, Vargas R, McMahon FG. Renovascular effects of nonprescription ibuprofen in elderly hypertensive patients with mild renal impairment. Pharmacotherapy 1993;13:143-8
31. Griffin MR, Yared A, Ray WA. Nonsteroidal anti-inflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 2000;151:488-96
32. Garcia-Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:769-72
33. Stürmer T, Erb A, Keller F, Gürner KP, Brenner H. Determinants of impaired renal function with use of nonsteroidal anti-inflammatory drugs: the importance of half-life and other medications. Am J Med 2001;111:51-7
34. Bonney SL, Northington RS, Hedrich DA, Walker BR. Renal safety of two analgesics used over-the-counter: ibuprofen and aspirin. Clin Pharmacol Ther 1986;40:373-7
35. Bradley JD, Brandt KD Katz BP, Kalasinski LA, Ryan SI. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991;325:87-91
36. Cummings DM, Amadio P, Nettler S, Freedman M. Office-based evaluation of renal function in elderly patients receiving non-steroidal anti-inflammatory drugs. J Am Board Fam Pract 1988;1:77-80
37. Fox DA, Jick H. Non-steroidal anti-inflammatory drugs and renal disease. JAMA 1984;251:1299-1300
38. Moore N. Forty years of ibuprofen use. Int J Clin Pract 2003;135(suppl):28-31.
39. Moore N, Diris H, Martin K, et al. NSAID use profiles derived from reimbursement data in France. Therapie 2004;59:541-6
40. Moore N. Diclofenac potassium 12.5 mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety. Clin Drug Investig 2007;27:163-95
41. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284:1247-55
42. Perez-Gutthann S, Garcia-Rodriguez LA, Duque-Oliart A, Varas-Lorenzo C. Low-dose diclofenac, naproxen, and ibuprofen cohort study. Pharmacotherapy 1999;19:854-9
43. Henry D. Variability in risk of major upper gastrointestinal complications with individual NSAIDs. Importance of drug dose and half-life: results of meta analysis. In: Rainsford KD (ed). Side Effects of Anti-Inflammatory Drugs IV. Dordrecht: Kluwer Academic Publishers BV, 1997:327
44. Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin and other non-steroidal anti-inflammatory agents. Am J Med 1984;2:19-24
45. Barry WS, Meinzinger MM, Howse CR: Ibuprofen overdose and exposure in utero: results from a postmarketing voluntary reporting system. Am J Med 1984;77:35-9
46. Hall AH, Smolinske SC, Kulig KW, Rumack BH: Ibuprofen overdose - a prospective study. West J Med 1988;148:653-6
47. Volans JN, Fitzpatrick R. Human toxicity of ibuprofen. In: Rainsford KD (ed). Ibuprofen. A Critical Bibliographic Review. London: Taylor and Francis, Inc., 1999:539-60
48. Volans G, Monaghan J, Colbridge M. Ibuprofen overdose. Int J Clin Pract 2003;135(suppl):54-60
49. Perry SJ, Streete PJ, Volans GN. Ibuprofen overdose: the first two years of over-the-counter sales. Hum Toxicol 1987;6:173-8
50. Wood DM, Monaghan J, Streete P, Jones AL, Dargan PI. Fatality after deliberate ingestion of sustained-release ibuprofen: a case report. Critical Care 2006;10:R44